Pfenex One Step Closer To Teriparatide As FDA Accepts NDA
Executive Summary
Pfenex maintains it can introduce a follow-on version of Eli Lilly’s Forteo in the fourth quarter of this year, after receiving a target goal date of 7 October 2019 from the FDA.